Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

SILAC-based phosphoproteomics reveals new PP2A-Cdc55-regulated processes in budding yeast.

Baro B, Játiva S, Calabria I, Vinaixa J, Bech-Serra JJ, de LaTorre C, Rodrigues J, Hernáez ML, Gil C, Barceló-Batllori S, Larsen MR, Queralt E.

Gigascience. 2018 May 1;7(5). doi: 10.1093/gigascience/giy047.

2.

"Exosomics"-A Review of Biophysics, Biology and Biochemistry of Exosomes With a Focus on Human Breast Milk.

de la Torre Gomez C, Goreham RV, Bech Serra JJ, Nann T, Kussmann M.

Front Genet. 2018 Mar 27;9:92. doi: 10.3389/fgene.2018.00092. eCollection 2018. Review.

3.

Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes.

Ferrer I, García MA, González IL, Lucena DD, Villalonga AR, Tech MC, Llorens F, Garcia-Esparcia P, Martinez-Maldonado A, Mendez MF, Escribano BT, Bech-Serra JJ, Sabido E, de la Torre Gómez C, Del Rio JA.

Brain Pathol. 2018 Nov;28(6):965-985. doi: 10.1111/bpa.12593. Epub 2018 Feb 25.

PMID:
29396893
4.

Disulfide driven folding for a conditionally disordered protein.

Fraga H, Pujols J, Gil-Garcia M, Roque A, Bernardo-Seisdedos G, Santambrogio C, Bech-Serra JJ, Canals F, Bernadó P, Grandori R, Millet O, Ventura S.

Sci Rep. 2017 Dec 5;7(1):16994. doi: 10.1038/s41598-017-17259-4.

5.

Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC).

Llombart V, García-Berrocoso T, Bech-Serra JJ, Simats A, Bustamante A, Giralt D, Reverter-Branchat G, Canals F, Hernández-Guillamon M, Montaner J.

J Proteomics. 2016 Feb 5;133:100-112. doi: 10.1016/j.jprot.2015.12.011. Epub 2015 Dec 21.

PMID:
26718731
6.

Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.

Rosa M, Bech-Serra JJ, Canals F, Zajac JM, Talmont F, Arsequell G, Valencia G.

J Proteome Res. 2015 Aug 7;14(8):3162-73. doi: 10.1021/acs.jproteome.5b00104. Epub 2015 Jul 7.

PMID:
26090583
7.

A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation.

Esteve-Puig R, Gil R, González-Sánchez E, Bech-Serra JJ, Grueso J, Hernández-Losa J, Moliné T, Canals F, Ferrer B, Cortés J, Bastian B, Ramón Y Cajal S, Martín-Caballero J, Flores JM, Vivancos A, García-Patos V, Recio JÁ.

PLoS Genet. 2014 Oct 16;10(10):e1004721. doi: 10.1371/journal.pgen.1004721. eCollection 2014 Oct.

8.

Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1.

Martino-Echarri E, Fernández-Rodríguez R, Bech-Serra JJ, Plaza-Calonge Mdel C, Vidal N, Casal C, Colomé N, Seoane J, Canals F, Rodríguez-Manzaneque JC.

Oncotarget. 2014 Jun 30;5(12):4295-304.

9.

The mitochondrial intermembrane space oxireductase Mia40 funnels the oxidative folding pathway of the cytochrome c oxidase assembly protein Cox19.

Fraga H, Bech-Serra JJ, Canals F, Ortega G, Millet O, Ventura S.

J Biol Chem. 2014 Apr 4;289(14):9852-64. doi: 10.1074/jbc.M114.553479. Epub 2014 Feb 25.

10.

Surfing transcriptomic landscapes. A step beyond the annotation of chromosome 16 proteome.

Segura V, Medina-Aunon JA, Mora MI, Martínez-Bartolomé S, Abian J, Aloria K, Antúnez O, Arizmendi JM, Azkargorta M, Barceló-Batllori S, Beaskoetxea J, Bech-Serra JJ, Blanco F, Monteiro MB, Cáceres D, Canals F, Carrascal M, Casal JI, Clemente F, Colomé N, Dasilva N, Díaz P, Elortza F, Fernández-Puente P, Fuentes M, Gallardo O, Gharbi SI, Gil C, González-Tejedo C, Hernáez ML, Lombardía M, Lopez-Lucendo M, Marcilla M, Mato JM, Mendes M, Oliveira E, Orera I, Pascual-Montano A, Prieto G, Ruiz-Romero C, Sánchez del Pino MM, Tabas-Madrid D, Valero ML, Vialas V, Villanueva J, Albar JP, Corrales FJ.

J Proteome Res. 2014 Jan 3;13(1):158-72. doi: 10.1021/pr400721r. Epub 2013 Nov 5.

PMID:
24138474
11.

Guidelines for reporting quantitative mass spectrometry based experiments in proteomics.

Martínez-Bartolomé S, Deutsch EW, Binz PA, Jones AR, Eisenacher M, Mayer G, Campos A, Canals F, Bech-Serra JJ, Carrascal M, Gay M, Paradela A, Navajas R, Marcilla M, Hernáez ML, Gutiérrez-Blázquez MD, Velarde LF, Aloria K, Beaskoetxea J, Medina-Aunon JA, Albar JP.

J Proteomics. 2013 Dec 16;95:84-8. doi: 10.1016/j.jprot.2013.02.026. Epub 2013 Mar 14.

PMID:
23500130
12.

A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers.

Morancho B, Parra-Palau JL, Ibrahim YH, Bernadó Morales C, Peg V, Bech-Serra JJ, Pandiella A, Canals F, Baselga J, Rubio I, Arribas J.

Oncogene. 2013 Mar 14;32(11):1452-9. doi: 10.1038/onc.2012.152. Epub 2012 May 28.

PMID:
22641219
13.

Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity.

Lecube A, Poca MA, Colomé N, Bech-Serra JJ, Hernández C, García-Ramírez M, Gándara D, Canals F, Simó R.

J Neuroendocrinol. 2012 Jun;24(6):944-52. doi: 10.1111/j.1365-2826.2012.02288.x.

PMID:
22296024
14.

Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.

Andreu-Pérez P, Esteve-Puig R, de Torre-Minguela C, López-Fauqued M, Bech-Serra JJ, Tenbaum S, García-Trevijano ER, Canals F, Merlino G, Avila MA, Recio JA.

Sci Signal. 2011 Sep 13;4(190):ra58. doi: 10.1126/scisignal.2001936.

15.

ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin.

Malapeira J, Esselens C, Bech-Serra JJ, Canals F, Arribas J.

Oncogene. 2011 Apr 21;30(16):1912-22. doi: 10.1038/onc.2010.565. Epub 2010 Dec 20.

PMID:
21170088
16.

Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study.

Rodríguez CE, Arranz JA, Colomé N, Bech-Serra JJ, Canals F, Del Toro M, Riudor E.

Proteomics Clin Appl. 2009 Dec;3(12):1430-9. doi: 10.1002/prca.200800251. Epub 2009 Oct 7.

PMID:
21136962
17.

Increased apoptosis after autoimmune regulator expression in epithelial cells revealed by a combined quantitative proteomics approach.

Colomé N, Collado J, Bech-Serra JJ, Liiv I, Antón LC, Peterson P, Canals F, Jaraquemada D, Alvarez I.

J Proteome Res. 2010 May 7;9(5):2600-9. doi: 10.1021/pr100044d.

PMID:
20218732
18.

A multi-laboratory study assessing reproducibility of a 2D-DIGE differential proteomic experiment.

Bech-Serra JJ, Borthwick A, Colomé N; ProteoRed Consortium, Albar JP, Wells M, Sánchez del Pino M, Canals F.

J Biomol Tech. 2009 Dec;20(5):293-6. No abstract available.

19.

Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis.

Hellin JL, Bech-Serra JJ, Moctezuma EL, Chocron S, Santin S, Madrid A, Vilalta R, Canals F, Torra R, Meseguer A, Nieto JL.

Am J Kidney Dis. 2009 Nov;54(5):871-80. doi: 10.1053/j.ajkd.2009.07.011. Epub 2009 Sep 25.

PMID:
19781833
20.

HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation.

García-Castillo J, Pedersen K, Angelini PD, Bech-Serra JJ, Colomé N, Cunningham MP, Parra-Palau JL, Canals F, Baselga J, Arribas J.

J Biol Chem. 2009 Sep 11;284(37):25302-13. doi: 10.1074/jbc.M109.001982. Epub 2009 Jul 8.

21.

Quick two-dimensional differential in gel electrophoresis-based method to determine length and secondary structures of telomeric DNA.

Lyakhovich A, Bech-Serra JJ, Canals F, Surralles J.

Anal Biochem. 2009 Jan 15;384(2):356-8. doi: 10.1016/j.ab.2008.09.046. Epub 2008 Oct 5.

PMID:
18938127
22.

Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors.

Santiago-Josefat B, Esselens C, Bech-Serra JJ, Arribas J.

J Biol Chem. 2007 Mar 16;282(11):8325-31. Epub 2007 Jan 16.

23.

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.

Anido J, Scaltriti M, Bech Serra JJ, Santiago Josefat B, Todo FR, Baselga J, Arribas J.

EMBO J. 2006 Jul 12;25(13):3234-44. Epub 2006 Jun 22.

24.

Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis.

Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, Arribas J, Canals F.

Mol Cell Biol. 2006 Jul;26(13):5086-95.

25.

ADAMs, cell migration and cancer.

Arribas J, Bech-Serra JJ, Santiago-Josefat B.

Cancer Metastasis Rev. 2006 Mar;25(1):57-68. Review. No abstract available.

PMID:
16680572
26.

Recycling of cell surface pro-transforming growth factor-{alpha} regulates epidermal growth factor receptor activation.

Martínez-Arca S, Bech-Serra JJ, Hurtado-Küttner M, Borroto A, Arribas J.

J Biol Chem. 2005 Nov 4;280(44):36970-7. Epub 2005 Aug 29.

27.

Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway.

Villanueva de la Torre T, Bech-Serra JJ, Ruiz-Paz S, Baselga J, Arribas J.

Biochem Biophys Res Commun. 2004 Feb 20;314(4):1028-35.

PMID:
14751236

Supplemental Content

Loading ...
Support Center